Edna Lúcia Souza

Prof. Edna Lúcia Souza

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
LSLuiz Vicente Ribeiro Ferreira Silva-Filho
Luiz Vicente Ribeiro Ferreira Silva-Filho
PMPaulo José Cauduro Maróstica
Paulo José Cauduro Maróstica
RARodrigo Athanazio
Rodrigo Athanazio
FRFrancisco José Caldeira Reis
Francisco José Caldeira Reis
NDNeiva Damaceno
Neiva Damaceno
MSMarcela Duarte De Sillos
Marcela Duarte De Sillos

1 January 2024 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
AFAdriana Virgínia Barros Faiçal
Adriana Virgínia Barros Faiçal
LMLaís Ribeiro Mota
Laís Ribeiro Mota
DCDanilo D’ Afonseca Correia
Danilo D’ Afonseca Correia
LMLarissa Prazeres Monteiro
Larissa Prazeres Monteiro
ESEdna Lúcia Souza
Edna Lúcia Souza
RTRegina Terse-Ramos
Regina Terse-Ramos
To revise the impact of telehealth on the quality of life, reduction in pulmonary exacerbations, number of days using antibiotics, adherence to treatment, pulmonary function, emergency visits, hospitalizations, and the nutritional status of individuals with asthma and cystic fibrosis.

1 June 2020 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
MJMarcus Herbert Jones
Marcus Herbert Jones
PVPaula Cristina Vasconcellos Vidal
Paula Cristina Vasconcellos Vidal
FLFernanda Cordoba Lanza
Fernanda Cordoba Lanza
DSDanielle Corrêa França de Melo Franco Silva
Danielle Corrêa França de Melo Franco Silva
PPPaulo Márcio Pitrez
Paulo Márcio Pitrez
MMMaria de Fátima Bazhuni Pombo March
Maria de Fátima Bazhuni Pombo March
To generate reference values for spirometry in Brazilian children 3-12 years of age and to compare those values with the values employed in the equations currently in use in Brazil. This study involved healthy children, 3-12 years of age, recruited from 14 centers (primary data) and spirometry results from children with the same characteristics in six databases (secondary data). Reference equations by quantile regressions were generated after log transformation of the spirometric and anthropometric data. Skin color was classified as self-reported by the participants. To determine the suitability of the results obtained, they were compared with those predicted by the equations currently in use in Brazil. We included 1,990 individuals from a total of 21 primary and secondary data sources. Of those, 1,059 (53%) were female. Equations for FEV1, FVC, the FEV1/FVC ratio, FEF between 25% and 75% of the FVC (FEF25-75%) and the FEF25-75%/FVC ratio were generated for white-, black-, and brown-skinned children. The logarithms for height and age, together with skin color, were the best predictors of FEV1 and FVC. The reference values obtained were significantly higher than those employed in the equations currently in use in Brazil, for predicted values, as well as for the lower limit of normality, particularly in children with self-reported black or brown skin. New spirometric equations were generated for Brazilian children 3-12 years of age, in the three skin-color categories defined. The equations currently in use in Brazil seem to underestimate the lung function of Brazilian children 3-12 years of age and should be replaced by the equations proposed in this study.

19 October 2012 in Jornal de Pediatria
Verified
Journal Article
Open access
ESEdna Lúcia Souza
Edna Lúcia Souza
RGRenata Silva Girão
Renata Silva Girão
JSJuçara Magalhães Simões
Juçara Magalhães Simões
CRCarolina Ferraz Reis
Carolina Ferraz Reis
NGNaiara Araújo Galvão
Naiara Araújo Galvão
LSLeda Solano F. Souza
Leda Solano F. Souza
To determine the prevalence of lower respiratory tract infection (LRTI) due to Chlamydia trachomatis in newborn infants and to describe the clinical, laboratory, and radiological characteristics of the disease. A cross-sectional study carried out over a 12-month period. All infants up to 6 months of age admitted consecutively at the Centro Pediátrico Professor Hosannah de Oliveira of the Universidade Federal da Bahia in Salvador, Brazil, and diagnosed with LRTI according to clinical and/or radiological criteria were included in the study. C. trachomatis infection was diagnosed by the enzyme-linked immunosorbent assay (ELISA) for the detection of IgM-class antibodies. The prevalence of LRTI by C. trachomatis was determined and the prevalence ratios for the infection and clinical or laboratory variables were calculated. One hundred and fifty-one infants were submitted to serology for C. trachomatis and 15 (9.9%) tested positive. Chlamydial infection was found only in infants under 5 months of age, mainly in those aged under 2 months. Three of the infants with C. trachomatis infection were born by cesarean section. Conjunctivitis and eosinophilia had occurred in 33.3% of the cases. Chest X rays were abnormal in 92.0% of cases. There was an association between C. trachomatis infection and the duration of hospitalization exceeding 15 days (p = 0.0398) and oxygen therapy (p = 0.0484). There was a high prevalence of C. trachomatis respiratory infection in the population studied. The infection was associated with a more severe form of the disease, emphasizing the importance of testing pregnant women for this infection to avoid infection in the newborn infant.

1 September 2018 in Jornal de Pediatria
Verified
Journal Article
Open access
FNFernanda de S. Nascimento
Fernanda de S. Nascimento
NSNelson A. Sena
Nelson A. Sena
TFTatiane da A. Ferreira
Tatiane da A. Ferreira
CMCibele D.F. Marques
Cibele D.F. Marques
LSLuciana R. Silva
Luciana R. Silva
ESEdna Lúcia Souza
Edna Lúcia Souza
The aims of the study were to determine the frequency of hepatobiliary disease in patients with cystic fibrosis and to describe the sociodemographic, clinical, and laboratory profile of these patients. This was a retrospective, descriptive, and analytical study of 55 patients diagnosed with cystic fibrosis, aged between 3 months and 21 years, followed-up from January 2008 to June 2016 in a referral center. Medical records were consulted and sociodemographic, clinical and laboratory data, including hepatobiliary alterations, imaging studies, genetic studies, liver biopsies, and upper digestive endoscopies were registered. Hepatobiliary disease was diagnosed in 16.4% of the patients and occurred as an initial manifestation of cystic fibrosis in 55.6% of these cases. The diagnosis of hepatopathy occurred before or concomitantly with the diagnosis of cystic fibrosis in 88.9% of the children. All patients with hepatobiliary disease were considered non-white, with a predominance of females (77.8%) and median (IQR) of 54 (27-91) months. Compared with the group without hepatobiliary disease, children with liver disease had a higher frequency of severe mutations identified in the CFTR gene (77.8% vs. 39.6%, p=0.033) and severe pancreatic insufficiency (88.9% vs. 31.6%, p=0.007). The frequency of hepatobiliary disease was high, with a very early diagnosis of the disease and its complications in the studied series. A statistical association was observed between the occurrence of hepatobiliary disease and the presence of pancreatic insufficiency and severe mutations in the CFTR gene. It is emphasized that cystic fibrosis is an important differential diagnosis of liver diseases in childhood.

6 June 2022 in Jornal de Pediatria
Verified
Journal Article
Open access
CGCarolina Godoy
Carolina Godoy
DPDanielle C. Paixão
Danielle C. Paixão
NBNey Boa-Sorte
Ney Boa-Sorte
TATatiana Amorim
Tatiana Amorim
LSLuiz Vicente Ribeiro Ferreira Silva-Filho
Luiz Vicente Ribeiro Ferreira Silva-Filho
ESEdna Lúcia Souza
Edna Lúcia Souza
To analyze the performance of the cystic fibrosis (CF) newborn screening (NBS) program over its first five years in a Brazilian northeastern state. A population-based study using a screening algorithm based on immunoreactive trypsinogen (IRT)/IRT. Data were retrieved from the state referral screening center registry. The program performance was evaluated using descriptive indicators such as the results of an active search, coverage, newborn's age at the time of blood sampling, the time between sample collection and its arrival at the laboratory, and the child's age at diagnosis of disease. The public CF screening program covered 82.6% of the 1,017,576 births that occurred, with an accumulated five-year incidence of 1:20,767 live births. The median (25th-75th) age at diagnosis was 3.5 (2.3–7.3) months. The sampling before 7 days of life for the first IRT (IRT1) increased between 2013 and 2017 from 42.2 to 48.3%. Around 5% of IRT1 samples and 30% of the second samples were collected after 30 days of life. In the first and second stages of screening, 23.6% and 19.9% of the infants, respectively, were lost to follow-up. In both stages of screening, the samples were retained at the health units for a median (25th–75th) of 9.0 (7.0–13.0) days. The coverage by the CF-NBS program was satisfactory as compared to other Brazilian state rates and the percentage of IRT1 samples collected within the first week of life increased progressively. However, time of samples retention at the health units, inappropriate sampling, inherent methodological problems, and loss of follow-up need to improve.